Impact of Disease History on the Efficacy of Ritlecitinib in Patients With Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study. // JID Innovations. – URL: https://www.sciencedirect.com/science/article/pii/S2667026726000834?dgcid=rss_sd_all
Impact of Disease History on the Efficacy of Ritlecitinib in Patients With Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study. JID Innovations. https://www.sciencedirect.com/science/article/pii/S2667026726000834?dgcid=rss_sd_all
“Impact of Disease History on the Efficacy of Ritlecitinib in Patients With Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study.” JID Innovations.
@article{article51491,
title = {Impact of Disease History on the Efficacy of Ritlecitinib in Patients With Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study},
journal = {JID Innovations},
url = {https://www.sciencedirect.com/science/article/pii/S2667026726000834?dgcid=rss_sd_all}
}